Veru (VERU) Gains from Sales and Divestitures (2012 - 2025)
Veru (VERU) posted Gains from Sales and Divestitures of $15.03 million for fiscal Q4 2025 (quarter ended Sep 30, 2025), compared with $194,536 a year earlier.
Powered by 
Analysis
Veru (VERU) Gains from Sales and Divestitures (2012 - 2025) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Veru's Gains from Sales and Divestitures came in at $10.78 million, up 781.5% from FY2024.
- Annual Gains from Sales and Divestitures shows a four-year compound annual growth rate of -12.5% (FY2021 to FY2025).
- In prior fiscal years, Veru's Gains from Sales and Divestitures was $1.22 million in FY2024 (-78.6%), $5.72 million in FY2023 and $18.41 million in FY2021.
- The fiscal Q4 2025 figure stands as the highest quarterly Gains from Sales and Divestitures since fiscal Q1 2021.
- According to Business Quant data, Gains from Sales and Divestitures for the three prior fiscal quarters was $484,615 (Q3 2025), $974,303 (Q2 2025) and -$4.2 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Veru | 57.86 Mn | -52.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 15.03 Mn |
| Jun 30, 2025 | 484,615.00 |
| Mar 31, 2025 | 974,303.00 |
| Dec 31, 2024 | -4.20 Mn |
| Sep 30, 2024 | 194,536.00 |
| Jun 30, 2024 | 110,000.00 |
| Dec 31, 2023 | 918,372.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Dec 31, 2020 | 18.41 Mn |
| Sep 30, 2017 | -64,019.00 |
| Jun 30, 2017 | -5,504.00 |
| Dec 31, 2016 | -4,469.00 |
| Sep 30, 2016 | -203.00 |
| Jun 30, 2016 | -218.00 |
| Mar 31, 2016 | -167.00 |
| Dec 31, 2015 | -111.00 |
| Dec 31, 2014 | -3,483.00 |
| Sep 30, 2014 | -61.00 |
| Dec 31, 2013 | -430.00 |
API Access
Veru Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VERU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "VERU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=VERU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();